Medidata Solutions Inc., an electronic clinical data management solutions provider, will provide Pro-Pharmaceuticals Inc. with a state-of-the-art electronic data capture technology for an upcoming clinical trial for cancer research. Medidata’s RAVE will allow Pro-Pharmaceuticals to correctly and accurately analyze results from the clinical trial, which will examine the targeted delivery of chemotherapy drugs to cancer cells.

“Our goal is to gain valuable real-time insight into collected trial data and give our medical team effective tools for decision making that could enhance and accelerate the clinical trials and our drug development program,” says Eliezer Zomer, Pro-Pharmaceuticals vice president for product development and manufacturing. “We teamed with Medidata for our phase one clinical trial because of their comprehensive, state-of-the-art and easy-to-use electronic data capture capabilities as well as their rapid implementation times and professional standard of service.”

For more information, visit www.mdsol.com.

 …